AIM: PEGylated components have been widely used to reduce particle aggregation in serum and extend circulation lifetime for lipid- and polymer-based gene-delivery systems. However, PEGylation is known to interfere with cell interaction and intracellular trafficking, resulting in decreased biological activity. In the present study, the effect of cholesterol domains on PEGylated liposome-mediated gene delivery was evaluated by PEGylating formulations with and without a cholesterol domain, and also by altering the location of PEG on the particle surface (i.e., within or excluded from the domain). MATERIALS AND METHODS: Lipoplexes formulated with PEG-cholesterol or PEG-diacyl lipid were used to transfect various cell lines, including human and mouse cancer cells. Cellular uptake of lipoplexes was also quantified and compared with the transfection results. RESULTS: Our findings are consistent with previous work demonstrating that PEGylation reduces transfection rates; however, formulations in which PEG was incorporated into the cholesterol domain did not exhibit this detrimental effect. In some cell lines, the incorporation of PEG into the domain actually increased transfection rates, despite no enhancement of cellular uptake. DISCUSSION: These results suggest that the adverse alterations in intracellular trafficking that are a consequence of PEGylation may be avoided by utilizing delivery vehicles that allow PEG to partition into a cholesterol domain.
AIM: PEGylated components have been widely used to reduce particle aggregation in serum and extend circulation lifetime for lipid- and polymer-based gene-delivery systems. However, PEGylation is known to interfere with cell interaction and intracellular trafficking, resulting in decreased biological activity. In the present study, the effect of cholesterol domains on PEGylated liposome-mediated gene delivery was evaluated by PEGylating formulations with and without a cholesterol domain, and also by altering the location of PEG on the particle surface (i.e., within or excluded from the domain). MATERIALS AND METHODS: Lipoplexes formulated with PEG-cholesterol or PEG-diacyl lipid were used to transfect various cell lines, including human and mousecancer cells. Cellular uptake of lipoplexes was also quantified and compared with the transfection results. RESULTS: Our findings are consistent with previous work demonstrating that PEGylation reduces transfection rates; however, formulations in which PEG was incorporated into the cholesterol domain did not exhibit this detrimental effect. In some cell lines, the incorporation of PEG into the domain actually increased transfection rates, despite no enhancement of cellular uptake. DISCUSSION: These results suggest that the adverse alterations in intracellular trafficking that are a consequence of PEGylation may be avoided by utilizing delivery vehicles that allow PEG to partition into a cholesterol domain.
Authors: Fuxin Shi; Luc Wasungu; Anita Nomden; Marc C A Stuart; Evgeny Polushkin; Jan B F N Engberts; Dick Hoekstra Journal: Biochem J Date: 2002-08-15 Impact factor: 3.857
Authors: C Allen; N Dos Santos; R Gallagher; G N C Chiu; Y Shu; W M Li; S A Johnstone; A S Janoff; L D Mayer; M S Webb; M B Bally Journal: Biosci Rep Date: 2002-04 Impact factor: 3.840
Authors: P Tam; M Monck; D Lee; O Ludkovski; E C Leng; K Clow; H Stark; P Scherrer; R W Graham; P R Cullis Journal: Gene Ther Date: 2000-11 Impact factor: 5.250
Authors: Mangesh C Deshpande; Martyn C Davies; Martin C Garnett; Philip M Williams; David Armitage; Lindsey Bailey; Maria Vamvakaki; Steven P Armes; Snjezana Stolnik Journal: J Control Release Date: 2004-05-31 Impact factor: 9.776
Authors: Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy Journal: J Control Release Date: 2018-07-17 Impact factor: 9.776
Authors: D Pozzi; C Marchini; F Cardarelli; F Salomone; S Coppola; M Montani; M Elexpuru Zabaleta; M A Digman; E Gratton; V Colapicchioni; G Caracciolo Journal: Biochim Biophys Acta Date: 2013-12-01
Authors: Arafa Musa; Abeer H Elmaidomy; Ahmed M Sayed; Sami I Alzarea; Mohammad M Al-Sanea; Ehab M Mostafa; Omina Magdy Hendawy; Mohamed A Abdelgawad; Khayrya A Youssif; Hesham Refaat; Eman Alaaeldin; Usama Ramadan Abdelmohsen Journal: Int J Nanomedicine Date: 2021-06-04